Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: A single institution's comprehensive experience

Clinical Oncology

Volumn 26, Issue 11, 2014, Pages 713-719

  Thibault, I ^a   Poon, I ^a   Yeung, L ^b   Erler, D ^a   Kim, A ^a   Keller, B ^a   Lochray, F ^a   Jain, S ^c   Soliman, H ^a   Cheung, P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Colorectal cancer; Lung metastases; Non small cell lung cancer; Oligometastases; Stereotactic body radiotherapy

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; COMORBIDITY; DOSIMETRY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; METASTASIS; NON SMALL CELL LUNG CANCER; OXYGEN THERAPY; PREDICTIVE VALUE; PRESCRIPTION; PRIMARY TUMOR; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RIB FRACTURE; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT FAILURE; TREATMENT PLANNING; VERY ELDERLY; ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; CANCER STAGING; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; COLORECTAL NEOPLASMS; COMPUTER ASSISTED RADIOTHERAPY; FOLLOW UP; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RADIATION PNEUMONITIS; RADIOSURGERY; RETROSPECTIVE STUDY; SECONDARY; SURVIVAL RATE;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COLORECTAL NEOPLASMS; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIATION PNEUMONITIS; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84908094643     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2014.06.018     Document Type: Article

References (15)

1. Tree A.C., Khoo V.S., Eeles R.A., et al. Stereotactic body radiotherapy for oligometastases. Lancet Oncol 2013, 14:e28-e37.
2. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63:1427-1431.
3. Onishi H., Shirato H., Nagata Y., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2:S94-S100.
4. Chi A., Liao Z., Nguyen N.P., et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 2010, 94:1-11.
5. Senthi S., Lagerwaard F.J., Haasbeek C.J., et al. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. Lancet Oncol 2012, 13:802-809.
6. Takeda A., Kunieda E., Ohashi T., et al. Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer. Radiother Oncol 2011, 101:255-259.
7. Trakul N., Chang C.N., Harris J., et al. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors. Int J Radiat Oncol Biol Phys 2012, 84:231-237.
8. Han K., Cheung P., Basran P.S., et al. A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors. Radiother Oncol 2010, 95:103-108.
9. Han K., Basran P.S., Cheung P. Comparison of helical and average computed tomography for stereotactic body radiation treatment planning and normal tissue contouring in lung cancer. Clin Oncol (R Coll Radiol) 2010, 22:862-867.
10. Milano M.T., Katz A.W., Zhang H., et al. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 2012, 83:878-886.
11. Chang D.T., Swaminath A., Kozak M., et al. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer 2011, 117:4060-4069.
12. Baba F., Shibamoto Y., Ogino H., et al. Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size. Radiat Oncol 2010, 5:81.
13. Matsuo Y., Shibuya K., Nagata Y., et al. Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011, 79:1104-1111.
14. Ohri N., Werner-Wasik M., Grills I.S., et al. Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group. Int J Radiat Oncol Biol Phys 2012, 84:e379-e384.
15. Dunlap N.E., Yang W., McIntosh A., et al. Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012, 84:1071-1077.